Study ID: TBB-COPD-201

Study Title

To Compare the Pharmacokinetics of Tiotropium in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

Teva Identifier

TBB-COPD-201

ClinicalTrials.gov Identifier

NCT01785433

Study Status

Completed

Trial Condition(s)

COPD

Interventions

Drug: Tiotropium HFA BAI 4.5 mcg | Drug: Tiotropium HFA BAI 9.0 mcg | Drug: SPIRIVAֲ® HandiHalerֲ® 18 mcg/day | Drug: Spirivaֲ® Respimatֲ® 5 mcg/day

Study Description

Please refer to ClinicalTrials.gov for a description of the trial
ClinicalTrials.gov study records with inclusion and exclusion criteria

Key Participation Requirements

Gender

Female, Male

Age Range

40 Years to 80 Years

Trial Duration

01/01/2013 - 08/01/2013

Phase

Phase 1/2

Study Type

Interventional